MICHAEL M. TAKAMURA, M.D.

Office Address: ***** Pomerado Road, Suite E -3

Poway, CA 92064

858-***-****, Fax 858-***-****

abpmw5@r.postjobfree.com

Experience

*/****-******* ****** ** SAN DIEGO, Forensic Examination Unit San Diego, CA

Part-time forensic psychiatrist. Working closely with San Diego Superior Courts, doing a variety of criminal and civil

forensics cases. Experience in competency to stand trial, sanity, Mentally Disordered Offender (MDO), LPS

conservatorship, Pre-Sentcencing, and Opiate Addiction Disposition evaluations. Experience with expert witness

testimonies. References: David Naimark, MD, Matthew Carroll, MD.

3/2010-present AURORA BEHAVIORAL HEALTH CARE San Diego, CA

Full-Time Inpatient Psychiatrist and Clinical Service Director of Adult Services Unit. Responsibilities include clinical

oversight of voluntary inpatient unit, directing treatment teams, supervising post -doc students, and meeting with

utilization review staff to regularly coordinate care of patients, in addition to running monthly unit staff meetings to

guide direction of clinical care issues.

References: Jim Plummer (CEO), Tho mas Flanagan MD (Medical Director), Chris Benbow MD (colleague).

12/2007-present CALIFORNIA NEUROPSYCHOPHARMACOLOGY RESEARCH INST (CNRI) San Diego, CA

Consult Physician / Sub-Investigator for a variety of clinical trials protocols in psychopharmacolog y.

References: Tram Johnson, Ph.D., Chris Benbow, MD.

7/2006-present PRIVATE PRACTICE, Adult and Forensic Psychiatrist Poway, CA

Outpatient practice, part -time. Clinical and forensic diagnosis and treatment of psychiatric conditions. Specializations

include primarily medication management of mood and anxiety disorders, substance abuse treatment (including

Suboxone), and psychotic disorders, but also include short term/brief psychotherapy, EAP referrals, sex offender

monitoring and treatment, worker s compensations cases (including treatment), and select criminal forensic cases. State

of California Certified Qualified Medical Examiner (QME) as of 11/2009 to present date.

QME/AME satellite offices located in: Chula Vista, Carlsbad.

References: Bernard Bogard MD, Anna Carrillo MD, Elizabeth Bryant Ph.D., Joshua Hall, MD, Ph.D

11/2008-2/2010 KAISER PERMANENTE MEDICAL GROUP Point Loma, CA

Per diem psychiatrist at CDRP (Chemical Dependency and Rehabitation Program). Work in urgent care setting, doin g

outpatient detoxes and admitting to inpatient unit, triage work, follow -up on outpatient basis. Psychoeducation, family

intervention, staff support services performed. Suboxone certified. Left job to go back to inpatient directorship at Aurora

Hospital.

References: Lawrence Moodie MD (Medical Director), Vanessa Greenwood MD.

7/2006-5/2009 AURORA BEHAVIORAL HEALTH CARE San Diego, CA

Full-Time Inpatient Psychiatrist and Clinical Service Director of Outpatient Programs. Responsibilities include clinical

oversight of Partial Hospitalization Program (PHP) and Intensive Outpatient Program (IOP), directing treatment teams,

running group therapies, supervising post -doc students, and meeting with utilization review staff to regularly coordinate

care of patients.

References: Jim Plummer (CEO), Thomas Flanagan MD (Medical Director), Mitch Gluck (Admin Head).

12/2007-12/2008 MEDICAL DIRECTOR (Psychiatry) CARESOUTH HOME HEALTH El Cajon, CA

Medical Director of Psychiatry Division of Home Health Agency. Re sponsibilities include oversight and consultation of

psychiatric home health nursing care, bimonthly treatment team meetings, public speaking engagements on behalf of

CareSouth, and business development planning. Discontinued service due to program being p hased out.

Version date February 2007 Page 1 of 5

References: Susan Erickson LVN, Sharon DePeralta RN/MBA, Suzette Kelley RN.

8/2005-9/2006 PRIVATE PRACTICE, Psychiatrist Sherman Oaks, CA

Outpatient psychiatry practice, part -time. Adult-Adolescent Mental Health Clinic. Experience in work ing with adults and

select adolescents with a variety of psychiatric illness, including mood, anxiety, thought, and substance abuse disorders.

Discontinued due to moving back to San Diego.

References: Alex Korchmarev, M.D., Nelli Korchmarev, Business Mgr, and Margaret Altman, LCSW.

2/2005-9/2006 PACIFIC HEALTH SYSTEMS La Mesa, CA

Inpatient Psychiatrist for weekend coverage at 2 psychiatric hospitals: University Community Medical Center and

Alvarado Parkway Institute.

References: Dr. Saleem Ishaque, Mohammed Bari, Brad Sanders.

7/2004-9/2006 PSYCHIATRIC CENTERS IN SAN DIEGO (PCSD) San Diego, CA

Contract psychiatrist for the San Diego Sheriff Department. Responsibilities include covering 4 local jails. Perform

initial assessments, follow-up medication management visits, inpatient units, safety cells evaluations, and supportive

therapy.

References: Drs. Sabah Chammas (PCSD), Dee Ann Wong (PCSD), Ari Albala (PCSD), Earl Goldstein (SD Sheriffs).

8/2003-9/2006 SHARP HEALTHCARE SYSTEMS San Diego, CA

Inpatient Psychiatrist for weekend coverage at 2 Sharp Hospitals: Sharp Mesa Vista and Sharp Grossmont. Includes

Seclusion & Restraint Coverage.

References: Drs. Michael Plopper (SMV), Brian Miller (GH), John Otis (GH).

6/2003-3/2005 CAL PSYCH COVERAGE (CPC) La Mesa, CA

Inpatient Unit Psychiatrist for weekend coverage at 2 private psychiatric hospitals: Alvarado Parkway Institute and

Aurora Behavioral Health. Work with Locked Intensive Care units, Forensic/INS units, Adolescent & Senior units,

Open Adult Unit, and Seclusion & Restraint Coverage. Discontinued when company closed 3/2005.

References: Drs. Mike Lardon, David Marks, Bernard Bogard.

2/2003-1/2004 REGISTRY OF PHYSICIAN SPECIALISTS Walnut Creek, CA

Contract Outpatient Psychiatrist at Pleasant Valley State Prison and Centinela State Prison of the California Dept of

Corrections. Work with inmate population with emphasis on outpatient follow -up visits, emergency forensic evaluations,

oncall responsibilities. Reason for leaving: ot her weekend work closer to San Diego.

2/2003-1/2004 NATIONAL MEDICAL REGISTRY San Clemente, CA

Contract Outpatient and Inpatient Psychiatrist at Pleasant Valley State Prison and Centinela State Prison. Work with

inmate population with emphasis on psychopharmacology, brief psychotherapy, especially with the sensitive -need

(sexual predator, homosexual, ex-gang member) populations.

References: Drs. Bill Alvarez (PVSP), Linda Francis (PVSP), Alan Abrams (CSP). Reason for leaving: other weekend

work closer to San Diego.

6/1998-9/1998 UCLA HEALTH SERVICES RESEARCH & DEPT. OF GERIATRICS Los Angeles, CA

Principal Investigator in a project to develop a disease-targeted quality-of-life (QOL) outcome assessment

instrument for stroke patients. Co -investigators: Dr. Ron Hays, UCLA Health Services Research and RAND

Corporation; Dr. Dilip Jeste, UCSD VA Geropsychiatry.

6/1996-12/1996 HARVARD MEDICAL SCHOOL Cambridge, MA

Research assistant in the Laboratory of Neurophysiology. Collaborated in study concer ning

thecardiorespiratory mechanisms of REM sleep, a joint collaboration among Drs. James Allan Hobson, Richard

Verrier, and James Quattrochi. Experience with neurosurgical techniques in cats, e.g. implanting EEG, EMG,

EOG, as well as cholinergic and adre nergicpharmacology.

Version date February 2007 Page 2 of 5

Education

7/2006-present UNIVERSITY OF CALIFORNIA, SAN DIEGO Dept of Psychiatry La Jolla, CA

Assistant Clinical Voluntary Professor

Responsibilities include weekly supervision of PGY-1 or 2 resident(s). Involves teaching of case discussions, journal

article reviews, psychotherapy case formulations, medication treatment strategies, psychiatry and the law, and resident

support and career mentoring.

6/2005-6/2006 UNIVERSITY OF SOUTHERN CALIFORNIA Dept of Psychiatry Los Angeles, CA

Post-residency fellowship in forensic psychiatry.

Fellow at the USC Institute of Psychiatry, Law and Behavioral Science

USC Keck School of Medicine, Department of Psychiatry and Behavioral Science

Clinical:

Psychiatric-Legal evaluations for attorneys and judges, in criminal, juvenile, and dependency law.

Treatment and Evaluation of Mentally Disordered Offenders.

Academic Appointments:

Clinical Instructor in Psychiatry 7/1/05-7/1/06

USC Keck School of Medicine, Dept of Psychiatry and Behaviora l Science

Consultantships:

Los Angeles County Superior Courts, including Department 95 Mental Health Court

Los Angeles County Public Defender s Office

Los Angeles County Alternate Public Defender s Office

Los Angeles County District Attorney s Office

Los Angeles County Sheriff s Department, Twin Towers Correctional Facility

Los Angeles City Police Department

Los Angeles County Department of Mental Health

Los Angeles County Department of Health

Los Angeles County Department of Probations

Los Angeles County Department of the Coroner

LAC+USC Medical Center

Patton State Hospital, Atascadero State Hospital, US Federal Courts

6/2001-6/2005 UNIVERSITY OF CALIFORNIA, SAN DIEGO Dept of Psychiatry La Jolla, CA

Chief Resident Dept of Psychiatry, Veterans Administration Hospital 2004-2005

UCSD Outpatient Center Dual Diagnosis Team Psychiatrist 2003-2004

Resident physician in Department of Psychiatry, PRITE scores 95th+ percentiles 2001-2005

Awards:

UCSD Housestaff Physician of the Year (one only; selected by all dept chairs) 2005-2006

AADPRT Ginsburg Fellowship Award (seven awards nationally) 2005-2006

APA/GlaxoSmithKline (Falk) Leadership Fellow Award (ten awards nationwide) 2003-2005

American College of Psychiatrists Laughlin Fellow Award (fifteen i n nation) 2003-2004

Medical Education & Research Foundation (MERF) Scholarship Recipient 2002-2004

UCSD Kaiser Excellence-In-Teaching Award (two among UCSD housestaff) 2002-2003

Presentations:

APA 2005 Workshop on A Bitter Bill: What Every Physicia n Needs to Know May 2005

APA 2004 Workshop on Wherefore Neuroscience Participant May 2004

Dept of Psychiatry Grand Rounds Presenter: Time Limited Psychotherapy January 2004

Other:

License: Medical Board Of California, November 22, 2002 -2012, DEA November 30, 2002-2011

Version date February 2007 Page 3 of 5

Research: Senior research project studying effects of chemotherapy and depression on sleep variables in breast

cancer patients, with Dr. Sonia Ancoli-Israel.

9/1997-6/2001 UNIVERSITY OF CALIFORNIA, SAN DIEGO School of Medicine La Jolla, CA

Earned M.D. degree from the School of Medicine

Honors: Psychiatry clerkship, inpatient medicine, outpatient psychiatry, emergency psychiatry, outpatient

medicine, emergency toxicology, and inpatient cardiology. OSCE exam: 2 nd highest grade in class.

4th highest grade in class on CPX patient exam. Near honors: neurology, pediatrics.

Honors/Awards:

UCSD School of Medicine 25th Anniversary Scholar ($2000x4) (1997 -2001)

Japanese Medical Society of America: Pharmaceutical Group Scholarship Award ($2 000) (1998)

Betty Ford Center Professional-In-Residence Program Scholarship ($1500) (1998)

American Federation for Aging Research (AFAR) Hartford UCLA Geriatrics Fellowship ($4500) (1998)

Other:

Professional memberships: AMA, APA, AAFP, American Society o f Addiction Medicine, ACOEM

9/1993-6/1997 HARVARD COLLEGE Cambridge, MA

Received Honors B.A. cum laude from the Dept. of Biology, with neuroscience focus. GPA: 3.65

Honors:

Dean s List (1993-97)

Harvard College Scholarship (1993-95)

John Harvard Scholarship (1995-97)

California State Robert Byrd Honors Scholarship (1993-97)

Harvard Research Program Scholarship (1995)

Winthrop House Best All-Around Award (1997)

Personal

Proficient in Japanese, Korean, and Spanish languages. Experience in inter preting and translating.

Hobbies: piano, Japanese tea ceremony, classical music, bicycling, travel, photography, fine dining.

Extracurricular

AMERICAN PSYCHIATRIC ASSOCIATION:

1. Member-In-Training (MIT) Representative 2002-2005, San Diego Psychiatric So ciety District Branch

2. Deputy Assembly Representative 6/2006-6/2008, San Diego Psychiatric Society District Branch.

3. Area 6 Early Career Psychiatrist Deputy Rep 6/2008-6/2010, California Psychiatric Association.

4. Area 6 Early Career Psychiatrist Rep 6/2010-6/2012, California Psychiatric Association

5. Assembly ECP Committee Chairperson, 5/2011-present.

6. Assembly Executive Council (AEC) Member, 5/2011-present.

7. Government Affairs Committee Member 2008-present, California Psychiatric Association.

8. California Psychiatric Association Access to Care Task Force member, 9/2011 -present.

9. APA Assembly - Reference Committee 4 Member, 2009-present.

10. Committee on Procedures Member (chaired by Glenn Martin, MD), 2010 -present.

11. Communications Champion Member (workgroup headed by Scot t Benson, MD) 8/2011-present.

12. Panelist ECP Workshop Transition to Practice and Transitions in Practice May 2012 Mtg.

13. APA Nominations Subcommittee Member, 7/2011-present.

SAN DIEGO COUNTY MEDICAL SOCIETY:

1. California Medical Association Young Phys icians Rep, 2008-present

Version date February 2007 Page 4 of 5

Other Professional Memberships:

American Association of Psychiatry and the Law (AAPL),

California Psychiatric Association (CPA),

American-Korean Association of Psychiatrists, (AKAP),

California Society of Industrial Medicine and Surgery (CSIMS).

J. William Fulbright Scholarship to Korea (1997-98)

Japan English Teaching (JET) program int l relations coordinator fellowship (Japanese Ministry of Education), 1997

Panelist on economic development: 49th Annual Japan-America Student Conference (Kyoto, Japan 1997)

Translator for Members of Japanese House of Representatives, and Korean former Prime Minister, at the Asia -Pacific

Forum (Harvard Kennedy School of Government)

Clinical Research Experience

Sub-Investigator for the following studies:

Astra Zeneca Protocol 5077IL/0089: Multi-center, open label, flexible dose, parallel group, evaluation of the

cataractogenic potential of Seroquel and Risperdal in the long term treatment of patients with schizophrenia or

schizoaffective disorder

Pfizer Protocol A1281143: A 3-week, double-blind, multi-center, placebo controlled study evaluating the

efficacy and safety of add-on oral ziprasidone in subjects with acute mania treated with Lithium or Divalproex

Sanofi-Aventis Protocol DRI6726: A 24-Week, Multicenter, Double-Blind, Randomized, Parallel-Group, Dose

Ranging Study of the Efficacy and Safety of oral doses of study drug and placebo on top of an established

treatment regimen of either olanzapine, risperidone or quetiapine monothera py in the treatment of Cognitive

Impairment in Schizophrenia

Novartis Protocol CAGO178A2303: An 8-week, multicenter,randomized, double-blind, placebo- and

paroxetine-controlled study of the efficacy, safety and tolerability of study drug given once daily in the

treatment of Major Depressive Disorder (MDD) followed by a 52 -week open-label treatment with study drug

Ortho Janssen McNeil Protocol R076477-SCH-4013: A blinded-initiation study of medication satisfaction in

subjects with schizophrenia treated wit h study drug after suboptimal response to oral risperidone

DSP Protocol D1050231: A Phase 3 Randomized, Placebo - and Active Comparator-Controlled Clinical Trial to

Study the Safety and Efficacy of Two Doses of Study Drug in Acutely Psychotic Patients with Schizophrenia.

Study Status: Ongoing

Protocol C10953/2032/DP/US: An 8-Week, Double-blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/day) as Adjunctive therapy in

Adults With Major Depression Associated With Bipolar I Disorder. Study Status: Ongoing

Alexa AMDC004301: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multi-Dose Efficacy

and Safety Study of Staccato Loxapine for Inhalation in Schizophrenic Patients with Agitation

Lundbeck Protocol 11723A: A randomized, double-blind, parallel-group, flexible-dose study exploring the

neurocognitive effect of study drug versus quetiapine in patients with schizophrenia using the MATRICS

Concensus Cognitive Battery (MCCB)

Sanofi-Aventis Protocol EFC10438: An eight -week, double-blind study to evaluate the efficacy, safety, and tolerability

of two fixed dose of study drug once daily in combination with paroxetine 20mg once daily compared to placebo in

combination with paroxetine 20mg once daily in patients with major depressive disorder

Version date February 2007 Page 5 of 5

Contact this candidate